Staidson (Beijing) BioPharmaceuticals Co., Ltd.
Status: Publicly traded
Direct answer
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is publicly traded on SHZ under the ticker 300204.SZ.
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional...
Can you invest in Staidson (Beijing) BioPharmaceuticals Co., Ltd.?
Yes. Staidson (Beijing) BioPharmaceuticals Co., Ltd. is publicly traded on SHZ under the ticker 300204.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Staidson (Beijing) BioPharmaceuticals Co., Ltd.
Detailed equity research is provided by MarketSnap.